Concordance among the three commercially available PD-L1 assays for esophageal squamous cell carcinoma

被引：0
|
作者：
Wang, Lizhen
Guo, Jhe-Cyuan
Chuang, Chien Huai
Cao, Grace
Huang, Stacey
Liu, Jia
Guo, Tony
Wu, Tsung-Che
Li, Shuang
Lin, Jing
King, Hsi-Yu
Cai, Jun
Yang, Wenjun
Liu, Qingyuan
Allen, Simon
Wang, Yifan
Zhang, Jingyu
Hsu, Chih-Hung
机构：
[1] Roche China Holding Ltd, Shanghai, Peoples R China
[2] Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan
[3] Natl Taiwan Univ, Biomed Pk Hosp, Hsinchu, Taiwan
[4] Genentech South San Francisco, San Francisco, CA USA
[5] Roche, Shanghai, Peoples R China
[6] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4058
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Concordance among three programmed death-ligand 1 (PD-L1) scoring methods and their association with clinical outcomes of tislelizumab (TIS) monotherapy in esophageal squamous cell carcinoma (ESCC).
    Shu, Yongqian
    Wang, Jufeng
    Chen, Zhendong
    Kim, Sung-Bae
    Lin, Chen-Yuan
    Kato, Ken
    Van Cutsem, Eric
    Du, Wenting
    Shi, Jingwen
    Xia, Tianyu
    Huang, Ruiqi
    Li, Qiao
    Zhang, Yun
    Shen, Zhirong
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 390 - 390
  • [22] Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma
    Magdalena Zajac
    Marietta Scott
    Marianne Ratcliffe
    Paul Scorer
    Craig Barker
    Hytham Al-Masri
    Marlon C. Rebelatto
    Jill Walker
    Diagnostic Pathology, 14
  • [23] Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma
    Zajac, Magdalena
    Scott, Marietta
    Ratcliffe, Marianne
    Scorer, Paul
    Barker, Craig
    Al-Masri, Hytham
    Rebelatto, Marlon C.
    Walker, Jill
    DIAGNOSTIC PATHOLOGY, 2019, 14 (01)
  • [24] Clinical relevance of PD-L1 and PD-L2 overexpression in patients with esophageal squamous cell carcinoma
    Hsieh, Chih-Cheng
    Hsu, Han-Shui
    Li, Anna Fen-Yau
    Chen, Yann-Jang
    JOURNAL OF THORACIC DISEASE, 2018, 10 (07) : 4433 - 4444
  • [25] Concordance between PD-L1 assays for metastatic renal cell carcinoma (mRCC) and metastatic urothelial carcinoma (mUC).
    Zhu, Jason
    Labriola, Matthew
    Cheris, Sachica
    Liu, Xin
    Perkinson, Kathryn
    Su, Zuowei
    McCall, Shannon
    Huang, Jiaoti
    Gupta, Rajan
    Armstrong, Andrew J.
    George, Daniel J.
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [26] Concordance between PD-L1 assays for metastatic renal cell carcinoma (mRCC) and metastatic urothelial carcinoma (mUC).
    Labriola, Matthew
    Zhu, Jason
    Cheris, Sachica
    Liu, Xin
    Perkinson, Kathryn
    Su, Zuowei
    McCall, Shannon
    Huang, Jiaoti
    Gupta, Rajan T.
    Armstrong, Andrew J.
    George, Daniel J.
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Independent prognostic role of PD-L1 expression in patients with esophageal squamous cell carcinoma
    Jiang, Dongxian
    Song, Qi
    Wang, Haixing
    Huang, Jie
    Wang, Hao
    Hou, Jun
    Li, Xiaojing
    Xu, Yifan
    Sujie, Akesu
    Zeng, Haiying
    Tan, Lijie
    Hou, Yingyong
    ONCOTARGET, 2017, 8 (05) : 8315 - 8329
  • [28] Molecular profiles of different PD-L1 expression in patients with esophageal squamous cell carcinoma
    Zhao, Songchen
    Hu, Xintong
    Zhou, Peiwen
    Li, Ang
    Chen, Liguo
    Wang, Duo
    He, Jiaxue
    Jiang, Yanfang
    CANCER BIOLOGY & THERAPY, 2023, 24 (01)
  • [29] C-Myc regulates PD-L1 expression in esophageal squamous cell carcinoma
    Liang, Ming-Qiang
    Yu, Feng-Qiang
    Chen, Chun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (02): : 379 - 388
  • [30] The Concentration of PD-L1 in the Peripheral Blood is a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma
    Akutsu, Y.
    Hanari, N.
    Murakami, K.
    Kano, M.
    Usui, A.
    Suioto, H.
    Takahashi, M.
    Matsumoto, Y.
    Otsuka, R.
    Matsubara, H.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S154 - S154
12345